- PureK Holdings (PKAN) has entered into a brand partnership with cannabis and CBD retailer Chemesis International (CSI)
- The deal also includes the company’s majority-owned CBD subsidiary, PureKana
- PureKana’s CBD products will be available at hundreds of Chemesis kiosks in high-traffic areas throughout the United States
- Chemesis kiosks employ AI for age verification, loss prevention and product education
- Chemesis International is a U.S. cannabis company focused on providing an artificially intelligent retail solution
- PureK Holdings leads an omni-channel platform with diversified assets in the emerging plant-based and holistic wellness consumer product categories
- Chemesis (CSI) is down 4.4 per cent and is currently trading at $0.87 per share
- PureK Holdings (PKAN) is down 0.67 per cent and is currently trading at $5.96 per share
PureK Holdings (PKAN) has entered into a brand partnership with cannabis and CBD retailer Chemesis International (CSI).
The deal also includes the company’s majority-owned CBD subsidiary, PureKana.
Under the partnership, PureKana’s CBD products will be available at hundreds of Chemesis kiosks in high-traffic areas throughout the United States.
PureKana’s range of products includes flavoured pure hemp-derived CBD oils, sleep aids, immunity boosts, vegan CBD-infused gummies, soothing CBD-infused topical creams and CBD capsules.
Chemesis’ kiosks run on its AI-powered VICKI Intelligent Self-Checkout platform, which features proprietary technology enabling age verification, loss prevention, product education and a virtual assistant.
Kathy Casey, CEO of PureK Holdings, commented,
“Our partnership with Chemesis accelerates our omni-channel distribution of the PureKana brand. CBD education, innovation and availability are foundational to our mission to enable wellness authentically every day for our loyal consumers.”
Josh Rosenberg, President of Chemesis, added,
“PureKana is a highly regarded brand by consumers and within the industry for their quality and well branded products. This partnership will allow Chemesis and PureKana to develop a cohesive strategy to bring high-quality products to consumers through an alternate route to market. Working with a strong brand such as PureKana will give the VICKI platform another edge over typical brick and mortar dispensaries.”
Chemesis International is a U.S. cannabis company focused on providing an artificially intelligent retail solution.
PureK Holdings leads an international omni-channel platform with diversified assets in the emerging plant-based and holistic wellness consumer product categories.
Chemesis (CSI) is down 4.4 per cent and is currently trading at $0.87 per share as of 11:09 am ET.
PureK Holdings (PKAN) is down 0.67 per cent and is currently trading at $5.96 per share as of 9:35 am ET.
